Publication | Closed Access

Expression of Excision Repair Cross-Complementation Group 1 as Predictive Marker for Nasopharyngeal Cancer Treated With Concurrent Chemoradiotherapy

Concurrent ChemoradiotherapySurgical OncologyMedicineNasopharyngeal Cancer TreatedSurgeryPredictive MarkerCancer TreatmentCancer GeneticsOncologyRadiation OncologyCancer Research